Drug Type Chemical drugs |
Synonyms |
Target |
Mechanism TACC3 inhibitors(Transforming acidic coiled protein 3 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Endometrial Carcinoma | Phase 1 | US | A2a Pharmaceuticals, Inc.Startup | 02 Nov 2023 |
Ovarian Cancer | Phase 1 | US | A2a Pharmaceuticals, Inc.Startup | 02 Nov 2023 |
Triple Negative Breast Cancer | Phase 1 | US | A2a Pharmaceuticals, Inc.Startup | 02 Nov 2023 |
Solid tumor | Preclinical | US | 17 Apr 2023 |